Public procurement is seen as a powerful instrument for innovation policy, but meaningful barriers seem to hinder its deployment. This study reviews literature on complexity, time consumption, and risk representing important hindrances for the procurement of innovation from public buyers' perspective. Findings provide evidence on the existence of hindrances for public procurement of innovation across European Union member states through the analysis of data from a large-scale survey. Further, differences in terms of the perception of barriers become evident depending on the availability of monitoring systems for innovation performance.
No takes yet. Share an insight, caveat, or question.
Amann et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: